A highly significant area under the curve (AUC = 0.92) was found for amnestic Mild Cognitive Impairment (aMCI) patients who will develop AD, suggesting 2D3A8-postive p53 as a prognostic biomarker for AD. The gene discussed is TP53; the disease is Cognitive impairment.